Atreca (BCEL) Short Interest Ratio & Short Volume

Short interest is the volume of Atreca shares that have been sold short but have not yet been covered or closed out. As of March 15th, traders have sold 148,000 shares of BCEL short. Learn More on Atreca's current short interest.

As of the most recent reporting period, the following institutional investors, funds, and major shareholders have reported short positions of Atreca: Concourse Financial Group Securities Inc., and Simplex Trading LLC. These positions are disclosed in Form 13F filings with the Securities and Exchange Commission.

Atreca saw a decrease in short interest in the month of March. As of March 15th, there was short interest totaling 148,000 shares, a decrease of 45.7% from the previous total of 272,700 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment.

Here is how the short interest of companies in the industry of "pharmaceutical preparations" compare to Atreca: 60 Degrees Pharmaceuticals, Inc. (0.75%), Phio Pharmaceuticals Corp. (0.47%), Aravive, Inc. (1.81%), TransCode Therapeutics, Inc. (0.61%), Onconetix, Inc. (3.17%), Agile Therapeutics, Inc. (12.68%), Sonoma Pharmaceuticals, Inc. (0.19%), Altamira Therapeutics Ltd. (28.13%), GeoVax Labs, Inc. (0.31%), NexImmune, Inc. (2.26%),

As of the most recent reporting period, the following stocks had the largest short interest positions: Cummins Inc. ($8.93 billion), Canadian Natural Resources Limited ($7.79 billion), Super Micro Computer, Inc. ($4.31 billion), T-Mobile US, Inc. ($4.00 billion), General Motors ($3.36 billion), Occidental Petroleum Co. ($3.10 billion), Charter Communications, Inc. ($2.92 billion), Coinbase Global, Inc. ($2.74 billion), Tractor Supply ($2.72 billion), and Moderna, Inc. ($2.31 billion). View all of the most shorted stocks.

Short selling BCEL is an investing strategy that aims to generate trading profit from Atreca as its price is falling. BCEL shares are trading up $0.01 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

A short squeeze for Atreca occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of BCEL, which in turn drives the price of the stock up even further.

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including BCEL, twice per month. The most recent reporting period available is March, 15 2024.